Pioneering Vaccine And Cell Culture Expert Joins HepaLife Technologies Inc. To Expedite Development Of Avian Flu Vaccine

January 16, 2007 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

BOSTON--(BUSINESS WIRE)--HepaLife Technologies, Inc. (OTCBB: HPLF) (FWB: HL1) (WKN: 500625) is pleased to announce the addition of Dr. Robert C. Tuttle to the Company’s Scientific Advisory Board.

Twitter
LinkedIn
Facebook
Email
Print

People